A patient undergoing chemotherapy with doxorubicin presents with shortness of breath, chest pain, bilateral crackles on lung auscultation, elevated jugular venous pressure, hyperkalemia, and hypercalcemia. What is the priority nursing intervention to stabilize the patient's condition?

A) Administer calcium gluconate to stabilize cardiac membranes

B) Initiate a high-flow oxygen therapy to improve oxygenation

C) Administer insulin with glucose to lower serum potassium levels

D) Provide intravenous fluids to enhance renal clearance of electrolytes

A patient undergoing chemotherapy with doxorubicin presents with shortness of breath, bilateral crackles, elevated jugular venous pressure, and sinus tachycardia. Laboratory tests indicate hyperkalemia and hypercalcemia. Which of the following interventions should the nurse prioritize to address the patient's current condition?

A) Administer calcium gluconate to stabilize cardiac membranes.

B) Initiate diuretics to reduce fluid overload.

C) Start a continuous infusion of sodium bicarbonate to correct metabolic acidosis.

D) Position the patient in a semi-Fowler's position to improve ventilation.

A patient receiving doxorubicin for cancer treatment is showing signs of chemotherapy-induced cardiomyopathy with a decreased ejection fraction and dyspnea. Which intervention should the nurse prioritize to address the patient's current symptoms and prevent further cardiac complications?

C) Prepare the patient for a consultation with cardiology for heart failure therapy

A) Administer diuretics to manage fluid overload

B) Initiate oxygen therapy to improve oxygen saturation

C) Prepare the patient for a consultation with cardiology for heart failure therapy

D) Monitor electrolyte levels closely to prevent further imbalances

A patient undergoing chemotherapy with doxorubicin presents with dyspnea, a decreased ejection fraction of 40%, and borderline oxygen saturation. Which nursing intervention is most appropriate to address the cardiopulmonary complications while considering the patient's current condition?

B) Administer diuretics as prescribed to manage fluid overload and monitor electrolyte levels closely.

A) Increase the rate of intravenous fluid administration to improve cardiac output.

B) Administer diuretics as prescribed to manage fluid overload and monitor electrolyte levels closely.

C) Initiate high-flow oxygen therapy to improve oxygen saturation levels.

D) Encourage the patient to ambulate frequently to enhance cardiac function and prevent complications.

A patient with a history of heart failure and recent initiation of low-dose furosemide and metoprolol therapy is experiencing increasing confusion and mild disorientation. Laboratory results show hyponatremia with a sodium level of 128 mmol/L. What is the nurse's priority action to address the patient's current condition?

B) Administer prescribed sodium supplementation and monitor neurological status.

A) Discontinue the furosemide and notify the physician immediately.

B) Administer prescribed sodium supplementation and monitor neurological status.

C) Increase the patient's fluid intake to correct sodium levels.

D) Initiate seizure precautions and prepare for possible imaging studies.

A patient with heart failure has been started on low-dose furosemide and metoprolol. After 48 hours, the patient develops confusion and a decreased Glasgow Coma Scale (GCS) score from 15 to 13. Laboratory results show a sodium level of 128 mmol/L. What is the priority nursing action?

C) Inform the physician immediately about the change in mental status.

A) Administer prescribed sodium chloride tablets to address hyponatremia.

B) Restrict fluid intake to prevent further dilutional hyponatremia.

C) Inform the physician immediately about the change in mental status.

D) Increase the furosemide dose to enhance diuresis and reduce fluid overload.

A patient with a history of cancer is undergoing treatment for electrolyte imbalance and presents with a low-grade fever and mild tachypnea. Which nursing intervention is the most appropriate initial action to address the patient's current respiratory status?

D) Place the patient in a high Fowler's position to facilitate lung expansion.

A) Administer supplemental oxygen to maintain oxygen saturation levels.

B) Increase the frequency of vital signs monitoring to every 15 minutes.

C) Encourage deep breathing exercises to improve ventilation.

D) Place the patient in a high Fowler's position to facilitate lung expansion.

A patient undergoing treatment for an electrolyte imbalance with a recent increase in sodium levels to 131 mmol/L presents with a low-grade fever, mild tachypnea, and is receiving broad-spectrum antibiotics. Which nursing intervention should be prioritized to address the patient's current condition?

D) Closely monitor fluid balance to prevent fluid overload and worsening respiratory symptoms.

A) Increase the frequency of neurological assessments to monitor for changes in orientation and GCS.

B) Initiate incentive spirometry to improve lung expansion and reduce the risk of pulmonary complications.

C) Administer antipyretics to manage the patient's fever and prevent further physiological stress.

D) Closely monitor fluid balance to prevent fluid overload and worsening respiratory symptoms.

A patient with a confirmed Gram-negative bacterial infection and signs of fluid overload is being managed with antibiotics and supportive respiratory care. Which nursing intervention is most appropriate to address the patient's current respiratory status while considering her fluid overload?

B) Position the patient in a high Fowler's position to facilitate lung expansion and ease breathing.

A) Increase the rate of intravenous fluid administration to ensure adequate hydration.

B) Position the patient in a high Fowler's position to facilitate lung expansion and ease breathing.

C) Discontinue oxygen therapy to prevent further respiratory distress.

D) Administer a diuretic as ordered to reduce fluid overload and improve respiratory function.

The patient with confirmed Gram-negative bacterial pneumonia is showing signs of fluid overload, including crackles upon lung auscultation and mild peripheral edema. Which intervention should the nurse prioritize to address the patient's current condition?

B) Administer a diuretic as prescribed to reduce fluid overload.

A) Increase the rate of intravenous fluids to maintain hydration.

B) Administer a diuretic as prescribed to reduce fluid overload.

C) Discontinue supplemental oxygen to prevent further respiratory issues.

D) Encourage the patient to drink more fluids orally to improve electrolyte balance.

oncology emergencies - Nursing Case Study

Pathophysiology

• Primary mechanism: Tumor lysis syndrome occurs when cancer cells release their contents into the bloodstream too rapidly, overwhelming the kidneys and leading to electrolyte imbalances, particularly hyperkalemia, hyperphosphatemia, and hypocalcemia.

• Secondary mechanism: Spinal cord compression results from tumor growth pressing on the spinal cord, causing reduced blood flow and potential nerve damage, leading to neurological deficits like paralysis if untreated.

• Key complication: Hypercalcemia of malignancy is driven by cancer cells increasing bone resorption or producing parathyroid hormone-related peptide, causing elevated calcium levels, leading to confusion, arrhythmias, or kidney failure.

Patient Profile

Demographics:

45-year-old female, high school teacher

History:

• Key past medical history: Breast cancer diagnosed 2 years ago, currently undergoing chemotherapy; hypertension

• Current medications: Doxorubicin, Lisinopril, Ondansetron

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and chest pain

• Key symptoms: Persistent dry cough, fatigue, mild fever, dizziness

• Vital signs: Temperature 38.2°C, blood pressure 100/60 mmHg, heart rate 115 bpm, respiratory rate 24 breaths per minute, oxygen saturation 89% on room air

Section 1

As the clinical team further evaluates the patient, initial assessment findings reveal bilateral crackles upon auscultation of the lungs, indicating possible fluid overload or pulmonary involvement. The patient's jugular venous pressure is elevated, suggesting potential cardiac involvement or impaired fluid clearance. Given the patient's recent chemotherapy with doxorubicin, a drug known for its cardiotoxic effects, the team considers the possibility of chemotherapy-induced cardiomyopathy contributing to her symptoms of shortness of breath and chest pain.

A 12-lead ECG is performed, revealing sinus tachycardia with non-specific ST segment changes, raising suspicion for myocardial strain or ischemia. Laboratory tests show markedly elevated serum potassium at 6.2 mmol/L, indicative of hyperkalemia potentially linked to tumor lysis syndrome. Calcium levels are also elevated at 11.5 mg/dL, confirming hypercalcemia of malignancy. These imbalances, combined with the patient's low blood pressure and high heart rate, suggest a complex interplay of oncological and treatment-related complications, necessitating prompt intervention to prevent further deterioration.

The team initiates immediate treatment to address the electrolyte imbalances: intravenous fluids are administered to help flush out excess potassium and calcium, and medications such as calcium gluconate and insulin with glucose are considered to stabilize cardiac membranes and temporarily shift potassium intracellularly. The patient is placed on supplemental oxygen to improve her saturation levels. This multifaceted approach aims to stabilize her hemodynamic status and correct critical imbalances, while plans are made for further cardiac imaging to assess for potential doxorubicin-induced cardiac dysfunction, thereby guiding ongoing management and monitoring for possible new complications.

Section 2

As the patient's treatment progresses, the clinical team closely monitors her response to the interventions. After administering intravenous fluids and medications to address the electrolyte imbalances, there is an initial improvement in her vital signs. Her heart rate decreases slightly to 110 beats per minute, and her blood pressure stabilizes at 100/60 mmHg, indicating a positive response to the fluid resuscitation. However, despite supplemental oxygen, her oxygen saturation remains borderline at 92%, and she continues to experience episodes of dyspnea.

New diagnostic results from a follow-up echocardiogram reveal a decreased ejection fraction of 40%, suggesting a significant compromise in cardiac function, likely attributable to the cardiotoxic effects of doxorubicin. This cardiac dysfunction correlates with the patient's clinical presentation of dyspnea and chest pain, reinforcing the suspicion of chemotherapy-induced cardiomyopathy. Additionally, repeat laboratory tests show a slight improvement in potassium levels, now at 5.8 mmol/L, but calcium levels remain elevated at 11.2 mg/dL, requiring ongoing management.

The team recognizes the need for further adjustments to the treatment plan. They consider the introduction of diuretics to manage fluid overload, carefully balancing the risk of exacerbating electrolyte disturbances. A decision is made to consult with cardiology for potential initiation of heart failure therapy, including beta-blockers or ACE inhibitors, to improve cardiac output and prevent further decline. The patient is closely monitored for any signs of worsening heart failure or new complications, such as arrhythmias, as the team continues to refine her comprehensive care plan. This coordinated approach aims to mitigate the cardiopulmonary strain, optimize her hemodynamic stability, and address the ongoing oncological challenges.

Section 3

Change in Patient Status

As the clinical team continues to implement the revised treatment plan, the patient's condition exhibits both improvements and new challenges. Over the next 48 hours, the introduction of low-dose furosemide begins to alleviate signs of fluid overload, evidenced by a reduction in peripheral edema and a slight increase in urine output. Concurrently, cardiology initiates a low-dose beta-blocker, metoprolol, to address the decreased ejection fraction and support cardiac function. This intervention is well-tolerated, with the patient's heart rate reducing further to 95 beats per minute.

However, despite these positive strides, the patient develops a new complication: increasing confusion and mild disorientation. Neurological assessment reveals no focal deficits, but the nurse notes that her Glasgow Coma Scale (GCS) score has decreased to 13 from a previously stable 15. Her blood pressure remains stable at 100/55 mmHg, but the heart rate is now fluctuating between 90 and 100 beats per minute. Repeat laboratory tests indicate a decline in sodium levels to 128 mmol/L, suggesting the onset of hyponatremia, possibly exacerbated by diuretic therapy and fluid management strategies.

The team recognizes the need to carefully balance fluid and electrolyte management while addressing this new development. A decision is made to adjust the diuretic regimen and consider sodium supplementation to correct the hyponatremia, preventing further neurological compromise. The patient's mental status and vital signs are closely monitored, with plans for additional imaging if her confusion persists. This emerging complication necessitates continual reassessment and adaptation of the care plan, emphasizing the importance of vigilant monitoring and dynamic clinical decision-making in managing complex oncology cases.

Section 4

In the subsequent 24 hours, the patient's response to the adjusted treatment plan provides both encouraging and concerning indicators. The adjustment in diuretic therapy, alongside cautious sodium supplementation, leads to a gradual improvement in her sodium levels, which increase to 131 mmol/L. Her orientation improves slightly, as she is now able to recall recent events and follow simple commands, raising her Glasgow Coma Scale (GCS) score to 14. This positive change suggests that the interventions are beginning to stabilize her electrolyte imbalance and reduce neurological symptoms. Her blood pressure remains stable, and her heart rate is now consistently between 90 and 95 beats per minute.

Despite these improvements, the patient develops a low-grade fever of 100.4°F, and she begins to exhibit mild tachypnea with a respiratory rate of 22 breaths per minute. Blood cultures are drawn, and empirical broad-spectrum antibiotics are initiated in response to a potential infection. A chest X-ray is ordered to rule out any pulmonary complications, particularly in the context of her recent fluid management and potential for opportunistic infections given her oncological status. The nursing team remains vigilant for any signs of sepsis, given her immunocompromised state.

As the clinical team awaits further diagnostic results, they remain focused on maintaining a delicate balance in the patient's treatment plan. The emerging fever and respiratory symptoms necessitate ongoing assessment and the potential for additional interventions. This situation underscores the complexity of managing oncology patients, as the team must continuously evaluate and address multiple, interrelated medical issues. The ability to adapt and respond to these dynamic changes is critical to optimizing patient outcomes and ensuring comprehensive care.

Section 5

As the clinical team continues to monitor the patient, new diagnostic results provide further insights into her condition. The chest X-ray reveals bilateral infiltrates, raising concerns about potential pneumonia, which aligns with her respiratory symptoms and low-grade fever. Blood culture results confirm the presence of a Gram-negative bacterial infection, prompting a refinement of the antibiotic regimen to target the identified pathogen more effectively. Concurrently, her complete blood count (CBC) shows leukocytosis, with a white blood cell count of 14,000/mm³, reinforcing the suspicion of an infectious process.

In response to these findings, the healthcare team intensifies antibiotic therapy, adding a specific agent known to combat Gram-negative bacteria. Additionally, they initiate supportive respiratory care, including supplemental oxygen to maintain her oxygen saturation levels above 92%. The nursing staff carefully monitor her respiratory status, observing any changes in breath sounds or increasing respiratory distress, which could indicate the need for more aggressive interventions such as bronchodilators or even mechanical ventilation if her condition deteriorates.

Despite the focused efforts to manage the infection, the patient's clinical status becomes more complicated. She begins to exhibit signs of fluid overload, likely exacerbated by the aggressive fluid resuscitation initially required to manage her electrolyte imbalance. Her lung auscultation now reveals crackles, and there is mild peripheral edema noted. This development necessitates a reassessment of her fluid management strategy, balancing the need to maintain adequate hydration and electrolyte status while avoiding further fluid accumulation. The interdisciplinary team, including nursing, pharmacy, and respiratory therapy, collaborates closely to adapt her care plan, demonstrating the intricate coordination required in managing complex oncology patients with overlapping medical challenges.